Document is current
Any future updates will be listed below
-
Authors
Burandt, Eike
Lübbersmeyer, Felix
Gorbokon, Natalia
Büscheck, Franziska
Luebke, Andreas M.
Menz, Anne
Kluth, Martina
Hube-Magg, Claudia
Hinsch, Andrea
Höflmayer, Doris
Weidemann, Sören
Fraune, Christoph
Möller, Katharina
Jacobsen, Frank
Lebok, Patrick
Clauditz, Till Sebastian
Sauter, Guido
Simon, Ronald https://orcid.org/0000-0003-0158-4258
Uhlig, Ria
Wilczak, Waldemar
Steurer, Stefan
Minner, Sarah
Krech, Rainer
Dum, David
Krech, Till
Marx, Andreas Holger
Bernreuther, Christian
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 22 January 2021
Accepted: 19 May 2021
First Online: 5 June 2021
Declarations
:
: The use of archived remnants of diagnostic tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, §12) and by the local ethics committee (Ethics Commission Hamburg, WF-049/09). All work has been carried out in compliance with the Helsinki Declaration.
: Not applicable.
: The Institute of Pathology of the UKE receives royalties on the sale of E-Cadherin clone MSVA-035 from MS Validated Antibodies GmbH (owned by a family member of GS).
